Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus and Development of Personalized Chronoprevention

NCT05645419 is registered in ClinicalTrials.gov with University Medical Center, Kazakhstan as lead sponsor.

NCT NCT05645419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05645419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus and Development of Personalized Chronoprevention
Lead sponsor
University Medical Center, Kazakhstan
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2023
Completion date
June 30, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical study